Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Combinatorial Chemistry & High Throughput Screening|April 8, 2003
Tetraacyldiborates: selective and efficient acylation reagents suitable for multiple parallel synthetic applicationsElmer J Gentry, Hanumaiah Telikepalli, Pusuluri Srinivas, et al.Organic & Biomolecular Chemistry|September 23, 2021
Hydrophilic and hydrophobic carboxamide pincers as anion hostsJessica Lohrman, Subhamay Pramanik, Sandeep Kaur, et al.Inorganic Chemistry|May 18, 2016
Pyrazinetetracarboxamide: A Duplex Ligand for Palladium(II)Jessica Lohrman, Hanumaiah Telikepalli, Thomas S Johnson, et al.Journal of Medicinal Chemistry|September 5, 2009
(3R,5S,7as)-(3,5-Bis(4-fluorophenyl)tetrahydro-1H-oxazolo[3,4-c]oxazol-7a-yl)methanol, a novel neuroprotective agentKelly E Desino, Sabah Ansar, Gunda I Georg, et al.Molecular Cancer Therapeutics|August 20, 2015
Altiratinib Inhibits Tumor Growth, Invasion, Angiogenesis, and Microenvironment-Mediated Drug Resistance via Balanced Inhibition of MET, TIE2, and VEGFR2Bryan D Smith, Michael D Kaufman, Cynthia B Leary, et al.Cancer Cell|April 13, 2011
Conformational control inhibition of the BCR-ABL1 tyrosine kinase, including the gatekeeper T315I mutant, by the switch-control inhibitor DCC-2036Wayne W Chan, Scott C Wise, Michael D Kaufman, et al.Cancer Cell|May 16, 2019
Ripretinib (DCC-2618) Is a Switch Control Kinase Inhibitor of a Broad Spectrum of Oncogenic and Drug-Resistant KIT and PDGFRA VariantsBryan D Smith, Michael D Kaufman, Wei-Ping Lu, et al.Journal of Medicinal Chemistry|May 13, 2015
Discovery of 1-(3,3-dimethylbutyl)-3-(2-fluoro-4-methyl-5-(7-methyl-2-(methylamino)pyrido[2,3-d]pyrimidin-6-yl)phenyl)urea (LY3009120) as a pan-RAF inhibitor with minimal paradoxical activation and activity against BRAF or RAS mutant tumor cellsJames R Henry, Michael D Kaufman, Sheng-Bin Peng, et al.Pageof 1